Growth hormone treatment: Pediatric to adult clinic transition;Traitement par hormone de croissance: Phase de transition de l'enfance à l'âge adulte

Revue Medicale Suisse

Volumn 1, Issue 6, 2005, Pages 426-431

  Fatio, Sandra ^a   Dirlewanger, Mirjam ^a   Meier, Christoph A ^a   Schwitzgebel, Valérie ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; GONADORELIN; HUMAN GROWTH HORMONE;

BODY HEIGHT; BONE MASS; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; MORBIDITY; MORTALITY; PATHOGENESIS; PROVOCATION TEST; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT PLANNING; DECISION TREE; METABOLISM; PHYSIOLOGY; RISK FACTOR;

DECISION TREES; GONADOTROPIN-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; RISK FACTORS;

EID: 17844385828     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. ESPE, Growth Hormone Deficiency During the Transition From Childhood to Adulthood. 10 Sept 2004, Basel.
2. nd revised and expanded edition. Mannheim: Johann Ambrosius Barth Verlag, Edition J & J, 1996.
3. Sperling MA. Pediatric Endocrinology, second edition, Saunders, an imprint of Elsevier Science, Amsterdam, 2002.
4. Thomas M. Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001. Eur J Endocrinol 2004;151:67-72.
5. Aimaretti G, Bellone S, Baldelli R, et al. Growth Hormone Stimulation Tests in Pediatrics. Endocrinologist 2004;14:216-21.
6. Geffner ME. Transition to the adult endocrine clinic: Testing pituitary function-what tests and when? Growth Horm IGF Res 2003;13:S117-S21.
7. Shalet SM. The Diagnosis of Growth Hormone Deficiency in children and adults. Endocrine Reviews 1998;19:203-23.
8. Blethen SL. Complications of growth hormone therapy in children. Curr Opin Pediatr 1995;7:466-71.
9. Attanasio AF. Continued Growth Hormone Treatement after Final Heigth Is Necessary to Complete Somatic Development in Childhood - Onset GH- Deficiency Patients. J Clin Endocrinol Metab 2004;89:4857-62.
10. Hintz RL. The Role of Auxologic and Growth Factor Measurments in the Diagnosis of Growth Hormone Deficiency. Pediatrics 1998;102:524-6.
11. Rappaport R. A 5-Year prospective Study of Growth Hormone (GH)- Deficient Children Treated with GH before the Age of 3 Years. J Clin Endocrinol Metab 1997;82:452-6.
12. Mills JL. Long- term mortality in the Unites States cohort of pituitary-derived growth hormone recipients. J Pediatr 2004;144:430-6.
13. Sklar CA. Risks of Disease Recurrence and Second Neoplasms in Survivors of Childhood Cancer Treated with Growth Hormone: A Report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87:3136-41.
14. Sklar C. Paying the Price for Cure - Treating Cancer Survivors with Growth Hormone. J Clin Endocrinol Metab 2000;12:4441-3.
15. Tauber M, Moulin P, Pienkowski C, et al. Growth Hormone (GH) Retesting and Auxological Data in 131 GH-Deficient Patients after Completion of Treatment J Clin Endocrinol Metab 1997;82:352-6.
16. Lissett CA, Shalet SM. Childhood-onset growth hormone (GH) deficiency in adult life. Best Pract Res Clin Endocrinol Metab 2002;16:209-24.
17. Drake WM, Howell SJ, Monson JP, et al. Optimizing GH Therapy in Adults and Children. Endocr Rev 2001;22:425-50.
18. Götherström G, Svensson J, Koranyi J, et al. A prospective Study of 5 Years of GH Replacement Therapy in GH-Deficient Adults: Sustained Effects on Body Composition, Bone Mass, and Metabolic Indices. J Clin Endocrinol Metab 2001;86:4657-65.